ArticlePathology oncology research : POR2019

BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.

Yuna Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.